Physician

Neal H Atebara, MD, FACS

According to 2025 Medicare claims, Neal Atebara, MD, FACS (NPI: 1093828840) practices ophthalmology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is RETINA CENTER OF HAWAII LLC (NPI: 1659328334; TIN: 990345804) and primary practice location at 96813-2439.

Atebara's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 622 traditional Medicare patients, billed 11,813 HCPCS/CPT codes, and received $543,358 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 409 prescription claims across 180 beneficiaries totaling $17,048 in drug costs, led by Nevanac (Nepafenac). Open Payments data shows 2 records totaling $144. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$300K$601K2015 Medicare payment: $540,570 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $545,473 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $600,527 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $497,277 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $536,619 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $401,556 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $418,514 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $440,400 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $536,072 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $543,358 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156785,328$540,570
20167006,101$545,473
20176936,786$600,527
20187196,503$497,277
20197126,614$536,619
20206263,552$401,556
20216244,110$418,514
20226204,999$440,400
202364011,662$536,072
202462211,813$543,358

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$31K2015 Drug cost: $31,013 (USD; Tot_Drug_Cst)2016 Drug cost: $16,565 (USD; Tot_Drug_Cst)2017 Drug cost: $10,704 (USD; Tot_Drug_Cst)2018 Drug cost: $11,707 (USD; Tot_Drug_Cst)2019 Drug cost: $12,214 (USD; Tot_Drug_Cst)2020 Drug cost: $13,275 (USD; Tot_Drug_Cst)2021 Drug cost: $14,613 (USD; Tot_Drug_Cst)2022 Drug cost: $14,980 (USD; Tot_Drug_Cst)2023 Drug cost: $12,742 (USD; Tot_Drug_Cst)2024 Drug cost: $17,048 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015146398$31,013
2016147361$16,565
2017139295$10,704
2018131266$11,707
2019128265$12,214
2020129276$13,275
2021120277$14,613
2022160387$14,980
2023166365$12,742
2024180409$17,048

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system5961,318$96
92134Imaging of retina5511,266$33
92250Photography of the retina97210$29
92201Extended exam of the back part of the eye with retinal drawing266402$20
92202Extended exam of the back part of the eye with optic nerve drawing397831$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NevanacNepafenac25457$8,422
Brimonidine TartrateBrimonidine Tartrate13383$2,057
TobramycinTobramycin2516,108$1,614
Prednisolone AcetatePrednisolone Acetate301,115$1,235
MoxifloxacinMoxifloxacin Hcl22348$632

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$144Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Neal H. Atebara, MD, FACS?

Tedicare shows public-source Medicare data for Neal H. Atebara, MD, FACS (NPI 1093828840), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Neal H. Atebara, MD, FACS have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Neal H. Atebara, MD, FACS?

Neal H. Atebara, MD, FACS is linked to RETINA CENTER OF HAWAII LLC (billing NPI 1659328334) in the available physician profile data.

Does Neal H. Atebara, MD, FACS have Open Payments data?

Neal H. Atebara, MD, FACS has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.